Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

640 public trials 137 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Completed

A Study of MM-111 in Patients With Advanced, Refractory Her2 Amplified, Heregulin Positive Cancers

NCT00911898

Conditions
Breast Diseases, Breast Neoplasms, Her2 Amplified Solid Tumors, +5 more
Locations
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Indiana University (IUPUI) Indianapolis, Indiana, United States
  • Fox Chase Center Philadelphia, Pennsylvania, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
View Trial Details
Completed

Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer

NCT00825734

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Providence Medical Group Terre Haute, Indiana, United States
  • RHHP/ Hope Cancer Center Terre Haute, Indiana, United States
  • Baptist Hospital East Louisville, Kentucky, United States
View all 15 locations
View Trial Details
Completed

Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer

NCT00915603

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Wilshire Oncology Medical Group LaVerne, California, United States
  • Eastern Connecticut Hematology Oncology Norwich, Connecticut, United States
  • Aventura Medical Center Aventura, Florida, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
View all 15 locations
View Trial Details
Completed

Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.

NCT01262469

Conditions
70 Years Old Patients and Over, After One Line of Chemotherapy With Trastuzumab, Breast Diseases, +6 more
Locations
  • Centre Paul Papin Angers, France
  • Centre Hospitalier de Beauvais Beauvais, France
  • Clinique Tivoli Bordeaux, France
  • Ch Fleyriat Bourg-en-Bresse, France
View all 20 locations
View Trial Details
Completed

BIG Molecular Screening Feasibility Study

NCT02094742

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • Klinikum Offenbach Offenbach, Frankfurt, Germany
  • Val d'Hebron Barcelona, Spain
  • University Hospital Dundee, United Kingdom
View Trial Details
Completed

Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer

NCT00924352

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Hematology Oncology PC Stamford, Connecticut, United States
  • Central Georgia Cancer Care Macon, Georgia, United States
  • Northwest Georgia Oncology Centers Marietta, Georgia, United States
  • North Shore Cancer Research Skokie, Illinois, United States
View all 13 locations
View Trial Details

Related conditions